Company: MDCXW
Filing Date: 2025-05-27
Form Type: S-1
Source: 0001062993-25-010394
Chunk: 75

Company: Medicus Pharma Ltd.
Filing Date: 2025-05-27
Form: S-1
Chunk 75
---
 |   |

<div align='center'>47</div>

General and administrative

General and administrative expenses for the three months ended March 31, 2025 and 2024 are comprised of:

|                                                           |     | Three months ended March 31, |      2025 |     |      2024 |     |           |   |
|:----------------------------------------------------------|:----|:-----------------------------|----------:|:----|----------:|:----|----------:|:--|
|                                                           |     |                              |         $ |     |         $ |     |    Change |   |
| Professional fees                                         |     |                              | 1,360,680 |     |   438,302 |     |   922,378 |   |
| Consulting fees                                           |     |                              |   284,946 |     |   455,814 |     |  (170,868 | ) |
| Salaries, wages and benefits                              |     |                              |   357,517 |     |   201,016 |     |   156,501 |   |
| General office, insurance and administration expenditures |     |                              |   539,696 |     |   177,810 |     |   361,886 |   |
| Business development and investor relations               |     |                              |   464,944 |     |    77,086 |     |   387,858 |   |
| Stock-based compensation                                  |     |                              |   112,277 |     |    35,953 |     |    76,324 |   |
|                                                           |     |                              | 3,120,060 |     | 1,385,981 |     | 1,734,079 |   |

Professional fees increased by $922,378 for the three months ended March 31, 2025, compared to the equivalent period in the prior year. The increase was primarily due to increases in legal and accounting fees related to the Company's operations. Professional fees include fees incurred for legal and accounting services that fluctuate from period to period based on the nature of the transactions the Company undertakes. The primary reason for the increase is due to increased regulatory requirements following the Company’s initial public offering and transition to U.S. domestic issuer status.

Consulting fees decreased by $170,968 for the three months ended March 31, 2025, compared to the equivalent period in the prior year. Consulting fees include fees